UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 177 filers reported holding UNIQURE NV in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $797,893 | +95.0% | 118,911 | +485.2% | 0.00% | 0.0% |
Q1 2023 | $409,245 | -62.9% | 20,320 | -58.3% | 0.00% | -66.7% |
Q4 2022 | $1,103,530 | +386.1% | 48,678 | +345.2% | 0.01% | +200.0% |
Q4 2021 | $227,000 | -70.2% | 10,934 | -35.5% | 0.00% | -81.8% |
Q2 2020 | $763,000 | – | 16,944 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |